It has been established that IFN-γ signaling acts downstream of notch signaling in HSC development and that IFN-γ could disrupt the expression of Notch target genes HES1 and HEY1 in patients with autoimmune diseases [45]. The gene discussed is HEY1; the disease is autoimmune disease.